| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $287,349 | 6 | 100 |
Sells | $0 | 0 | 0 |
| Goodman Robert Scott | Chief Executive Officer | 1 | $199,999 | 0 | $0 | $199,999 |
| Lin Yi-Chien | 10 percent owner | 4 | $62,352 | 0 | $0 | $62,352 |
| MOORHEAD DANIEL J | Chief Financial Officer | 1 | $24,998 | 0 | $0 | $24,998 |
Beyond Air, Inc. functions as a specialized entity involved in both the development of medical devices and biopharmaceutical solutions. A central part of its operations is the LungFit platform, an innovative system that generates and delivers nitric oxide. Within this platform, LungFit PH is currently available, used to address persistent pulmonary hypertension in infants. Furthermore, the company is advancing LungFit PRO, a product intended for various viral lung ailments like community-acquired viral pneumonia (including COVID-19) and …
Over the last 12 months, insiders at Beyond Air, Inc. have bought $287,349 and sold $0 worth of Beyond Air, Inc. stock.
On average, over the past 5 years, insiders at Beyond Air, Inc. have bought $1.89M and sold $733,892 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Goodman Robert Scott (Chief Executive Officer) — $199,999. Lin Yi-Chien (10 percent owner) — $62,352. MOORHEAD DANIEL J (Chief Financial Officer) — $24,998.
The last purchase of 2,607 shares for transaction amount of $5,761 was made by Lin Yi-Chien (10 percent owner) on 2026‑10‑13.
| 2026-10-13 | Lin Yi-Chien | 10 percent owner | 2,607 0.3651% | $2.21 | $5,761 | +0.91% | ||
| 2026-10-01 | Lin Yi-Chien | 10 percent owner | 15,393 2.0416% | $2.80 | $43,100 | -23.21% | ||
| 2026-09-30 | Lin Yi-Chien | 10 percent owner | 2,000 0.2725% | $2.71 | $5,420 | -17.59% | ||
| 2026-09-29 | Lin Yi-Chien | 10 percent owner | 3,000 0.3958% | $2.69 | $8,070 | -18.76% | ||
| 2026-07-29 | Goodman Robert Scott | Chief Executive Officer | 34,722 5.0376% | $5.76 | $199,999 | -43.19% | ||
| 2026-07-29 | MOORHEAD DANIEL J | Chief Financial Officer | 4,340 0.6297% | $5.76 | $24,998 | -43.19% | ||
| 2025-07-21 | Lisi Steven A. | CEO and Chairman of the Board | 6,000 0.0063% | $3.25 | $19,491 | -68.37% | ||
| 2025-03-14 | Carey Robert | director | 1M 1.0548% | $0.25 | $250,050 | -54.84% | ||
| 2025-02-19 | Gaul Michael A. | Chief Operating Officer | 6,000 0.0072% | $0.38 | $2,294 | -66.01% | ||
| 2024-09-26 | Lisi Steven A. | CEO and Chairman of the Board | 1.48M 4.2606% | $0.50 | $744,662 | -33.58% | ||
| 2024-09-26 | Carey Robert | director | 1.48M 4.2606% | $0.50 | $744,662 | -33.58% | ||
| 2024-08-15 | Lisi Steven A. | CEO and Chairman of the Board | 50,000 0.09% | $0.37 | $18,340 | -11.07% | ||
| 2024-08-14 | Carey Robert | director | 100,000 0.1947% | $0.40 | $39,680 | -16.25% | ||
| 2024-08-14 | Lisi Steven A. | CEO and Chairman of the Board | 100,000 0.1896% | $0.39 | $38,640 | -16.25% | ||
| 2024-08-14 | Lucera Erick | director | 39,266 0.0764% | $0.40 | $15,565 | -16.25% | ||
| 2023-12-28 | Sale | Avniel Amir | Chief Business Officer | 25,000 0.0789% | $2.06 | $51,451 | -69.52% | |
| 2023-12-27 | Sale | Myers Jeff Lynn | Chief Medical Officer | 3,423 0.0107% | $2.21 | $7,579 | -70.76% | |
| 2023-12-18 | Carey Robert | director | 1.2M 3.6746% | $1.64 | $1.96M | -34.34% | ||
| 2023-12-18 | Lisi Steven A. | CEO and Chairman of the Board | 77,775 0.2375% | $1.63 | $126,797 | -34.34% | ||
| 2023-11-16 | Gaul Michael A. | Chief Operating Officer | 10,000 0.0353% | $1.77 | $17,700 | -21.90% |
| Lin Yi-Chien | 10 percent owner | 148000 23.3205% | $343,360.00 | 4 | 0 | |
| Goodman Robert Scott | Chief Executive Officer | 34822 5.4869% | $80,787.04 | 1 | 0 | |
| MOORHEAD DANIEL J | Chief Financial Officer | 4340 0.6839% | $10,068.80 | 1 | 0 | |
| Carey Robert | director | 4076864 642.396% | $9.46M | 33 | 0 | <0.0001% |
| Lisi Steven A. | CEO and Chairman of the Board | 3327411 524.3039% | $7.72M | 22 | 4 | <0.0001% |
| BENTSUR RON | director | 144736 22.8062% | $335,787.52 | 1 | 26 | |
| Gaul Michael A. | Chief Operating Officer | 94150 14.8353% | $218,428.00 | 6 | 0 | <0.0001% |
| Lucera Erick | director | 43608 6.8714% | $101,170.56 | 2 | 0 | <0.0001% |
| BECK DOUGLAS | Chief Financial Officer | 22460 3.539% | $52,107.20 | 7 | 0 | |
| Forbes William P | director | 14855 2.3407% | $34,463.60 | 3 | 0 | |
| Lee Yoori | director | 12654 1.9939% | $29,357.28 | 2 | 0 | |
| Avniel Amir | Chief Business Officer | 0 0% | $0 | 3 | 25 |
$9,837,727 | 35 | 7.68% | $94.71M | |
$1,105,104 | 34 | -11.40% | $311.25M | |
$20,867,362 | 27 | -3.90% | $467.11M | |
$58,749,198 | 24 | 16.21% | $100.45M | |
$842,771 | 15 | 6.44% | $214.28M |
| Increased Positions | 8 | +18.6% | 86,706 | +5.04% |
| Decreased Positions | 16 | -37.21% | 309,615 | -17.99% |
| New Positions | 6 | New | 62,001 | New |
| Sold Out Positions | 6 | Sold Out | 62,037 | Sold Out |
| Total Postitions | 35 | -18.6% | 1M | -12.95% |
| Alyeska Investment Group, L.P. | $599.00 | 9.49% | 759,061 | +759,061 | New | 2025-09-30 |
| Balyasny Asset Management L.P. | $366.00 | 5.8% | 464,161 | +297,441 | +178.41% | 2025-09-30 |
| Vanguard Group Inc | $82.00 | 1.31% | 104,409 | +31,814 | +43.82% | 2025-09-30 |
| Bleichroeder Lp | $68.00 | 1.08% | 86,489 | +49,573 | +134.29% | 2025-09-30 |
| Lasry Marc | $65.00 | 1.02% | 81,950 | <1 | <0.01% | 2025-09-30 |
| Kingdon Capital Management, L.L.C. | $37.00 | 0.59% | 46,833 | <1 | <0.01% | 2025-09-30 |
| Geode Capital Management, Llc | $34.00 | 0.54% | 42,983 | +1,067 | +2.55% | 2025-09-30 |
| Wealth Effects Llc | $27.00 | 0.42% | 33,755 | +19,850 | +142.75% | 2025-09-30 |
| Baldwin Wealth Partners Llc/Ma | $24.00 | 0.39% | 30,800 | +15,400 | New | 2025-09-30 |
| Blackrock, Inc. | $17.00 | 0.28% | 22,033 | +<1 | +<0.01% | 2025-09-30 |